Dr. Susan Chi's clinical research focuses primarily on pediatric brain tumors, specifically in malignant infant tumors such as atypical teratoid rhabdoid tumor (ATRT), embryonal tumor with multilayered rosettes (ETMR), high-risk medulloblastoma and infant high-grade glioma.

After graduating from Princeton University, Dr. Susan Chi received her medical degree from Mount Sinai School of Medicine (New York, NY) and completed her pediatric residency at Yale/New Haven Hospital (New Haven, CT). After an additional chief residency year in New Haven, she then completed a Pediatric Hematology-Oncology fellowship at Memorial Sloan-Kettering Cancer Center (New York, NY), followed by a pediatric and adult neuro-oncology fellowship at NYU Medical Center (New York, NY).

She joined the Pediatric Hematology/Oncology faculty in 2003 and now serves as Clinical Director for Pediatric Neuro-Oncology at Dana-Farber Cancer Institute/Boston Children’s Hospital. She is an Institute Physician at Dana-Farber Cancer Institute and an Associate Professor of Pediatrics at Harvard Medical School.

Investigator of Clinical Trial: 

• TAZNI  (NCT05407441)